NFKB1 and Insulin resistance: Several signaling pathways, including IκB kinase (IKKβ)/NF-κB and c-Jun N-terminal kinase (JNK) pathways, which are activated in adipose tissues and the liver, may play an important role in inflammation-induced insulin resistance [50,56,57,58].